Aarti Pharmalabs Ltd has submitted a compliance certificate under Regulation 74(5) of SEBI for the quarter ended December 31, 2024, confirming securities were processed accordingly without any demat/remat requests.
AI Assistant
Aarti Pharmalabs Ltd
2025
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.